Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/chemdiv-to-participate-in-the-ef-hutton-annual-global-conference-may-15-2024-302143637.html
https://www.prnewswire.com/news-releases/chemdiv-marks-a-milestone-as-orionis-biosciences-novel-immunotherapy-enters-phase-i-clinical-trials-302025515.html
https://www.prnewswire.com/news-releases/chemdiv-helps-advance-virioms-influenza-treatment-to-successful-phase-i-clinical-trials-completion-302018412.html
https://www.prnewswire.com/news-releases/veteran-pharma-and-biotech-executive-bill-farley-named-new-ceo-of-chemdiv-302017515.html
https://www.prnewswire.com/news-releases/investigators-from-john-byrds-lab-at-university-of-cincinnati-presented-non-clinical-summary-data-for-the-best-in-class-selective-bcl2-inhibitor-clinical-candidate-developed-by-eilean-therapeutics-in-collaboration-with-chemdiv-302014320.html
https://www.prnewswire.com/news-releases/chemdiv-presented-non-clinical-summary-data-for-the-best-in-class-selective-flt3-clinical-candidate-at-the-65th-ash-annual-meeting-and-exposition-with-its-partners-and-sponsors-302013219.html
https://www.prnewswire.com/news-releases/chemdiv-welcomes-peter-dmitriev-and-david-stark-to-business-development-team-announces-headquarters-expansion-301968092.html